Top Penny Stocks For 2023

Shares in Marathon Digital (NASDAQ:MARA) are on the move again. A penny stock through half of 2020, MARA posted over 400% growth at the start of 2021 before shedding more than half its value by mid-May. Along the way, trading in MARA stock was even halted by the U.S. Securities and Exchange Commission (SEC).

Source: biggunsband /

And did I mention that this name’s primary business is mining Bitcoin (CCC:BTC-USD)? Those are two strikes for many investors. Plus, if you want a third, how about the fact that Marathon Digital is the parent company of notorious patent troll Uniloc?

That said, despite elements that may make investors turn up their noses, you can’t overlook Marathon’s success. After a meme-stock rollercoaster ride as well as drama in the crypto world, MARA stock is up 264% year-to-date (YTD). So, here’s a look at the good and the bad with this pick.

Top Penny Stocks For 2023: Nicholas Financial Inc.(NICK)

Nicholas Financial, Inc., through its subsidiaries, operates as a specialized consumer finance company. The company engages in acquiring and servicing contracts for purchases of new and used automobiles and light trucks. It also makes direct loans and sells consumer-finance related products. In addition, the company engages in developing, marketing, supporting, and updating industry-specific computer application software for small businesses located primarily in the Southeast United States. As of April 5, 2011, it operated 56 branch locations in 14 Southeastern and Midwestern states. The company was founded in 1986 and is headquartered in Clearwater, Florida.

Advisors’ Opinion:

  • [By Max Byerly]

    Nicholas Financial, Inc. (NASDAQ:NICK) major shareholder Adam K. Peterson acquired 5,500 shares of the company’s stock in a transaction that occurred on Thursday, August 9th. The shares were acquired at an average cost of $10.80 per share, for a total transaction of $59,400.00. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

  • [By Max Byerly]

    CPI Card Group (NASDAQ: PMTS) and Nicholas Financial (NASDAQ:NICK) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

  • [By Ethan Ryder]

    Nicholas Financial (NASDAQ: NICK) and Encore Capital Group (NASDAQ:ECPG) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

  • [By Stephan Byrd]

    Nicholas Financial (NASDAQ: NICK) and CPI Card Group (NASDAQ:PMTS) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Top Penny Stocks For 2023: China Pharma Holdings Inc.(CPHI)

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical products primarily to hospitals and private retailers in the People?s Republic of China. Its products include Bumetanide to treat edema diseases; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of brain; Cerebroprotein Hydroloysate injection for the treatment of memory decline and attention deficit; Buflomedil Hydrochloride for blood vessel diseases; Propylgallate and Ozagrel Sodium for the treatment of cerebral thrombosis, coronary heart disease, and thrombus deep phlebitis; and Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and lipoprotein blood diseases. The company also offers Cefaclor Dispersible tablets for tympanitis, lower respiratory tract, urinary tract, and skin/skin tissue infection; Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Clarithromycin granules and capsules for nasoph arynx, respiratory tract, and skin tissue infections; Naproxen Sodium and Pseudophedrine Hydrochloride Sustained Release tablets to relieve cold, sinus, and flu symptoms; Cefalexin capsules for acute tonsillitis; and Anhydroandrographolide for ischemic heart, cerebrovascular, and lipoprotein blood diseases. In addition, it provides Hepatocyte growth-promoting factor to treat viral hepatitis symptoms; Tiopronin to treat acute chronic Hepatitis B and relieve liver injury; Omeprazole to treat gastroesophageal reflux disease; Granisetron Hydrochloride injection for nausea and vomiting; Vitamin B6, an vitamin supplement; Thymopolypetides injection for treating diseases and tumors of various cells with reduced immunological function; and Recombined Human Fibroblast Growth Factor for the production of cosmetics. The company distributes its products through independent regional distributors and sales representatives. China Pharma Holdings, Inc. is based in Haikou, the People?s Repub lic of China.

Advisors’ Opinion:

  • [By Josh Enomoto]

    Unfortunately, the company’s latest financial disclosure revealed that marketplace revenue “plunged 29% from a year earlier as users shopped elsewhere.” That’s a particularly tough blow as ContextLogic essentially received free marketing during the lockdowns. Apparently, that wasn’t enough although if you’re a cup-half-empty type, WISH stock is discounted 30% over the trailing month.

    China Pharma Holdings (CPHI) Source: luchschenF /

    Before I get into this next company on our list of Discord stocks, let me start with a firm disclosure: I am not going to touch China Pharma Holdings with a ten-foot pole. That’s not to say that I’m bearish on CPHI or anything of that nature. I just don’t have the nerves of steel required to put my money at risk.

  • [By Logan Wallace]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get Scynexis alerts:

    Steady Activities: SCYNEXIS, Inc. (NASDAQ:SCYX), LPL Financial Holdings Inc. (NASDAQ:LPLA) ( Do Analysts Think You Should Buy – SCYNEXIS Inc (NASDAQ: SCYX) ( Notable Runner: SCYNEXIS, Inc. (SCYX) ( Most Active Stocks Now: SCYNEXIS, Inc. (NASDAQ:SCYX), China Pharma Holdings, Inc. (NYSE:CPHI), Kala … ( Overview on price to free cash flow: SCYNEXIS, Inc. (NASDAQ:SCYX), InfuSystem Holdings Inc. (NYSE:INFU) (

    Several research analysts have recently issued reports on the company. Roth Capital assumed coverage on Scynexis in a research note on Tuesday, May 8th. They set a “buy” rating and a $6.00 price target for the company. Seaport Global Securities assumed coverage on Scynexis in a research note on Tuesday, April 10th. They set a “buy” rating and a $4.00 price target for the company. Zacks Investment Research raised Scynexis from a “hold” rating to a “buy” rating and set a $1.25 price target for the company in a research note on Tuesday, May 8th. HC Wainwright assumed coverage on Scynexis in a research note on Monday, May 7th. They set a “buy” rating and a $5.00 price target for the company. Finally, ValuEngine raised Scynexis from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Scynexis currently has an average rating of “Buy” and an average target price of $4.45.

Top Penny Stocks For 2023: BioDelivery Sciences International Inc.(BDSI)

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) and Bioral cochleate drug delivery technologies in the development of its products. The BEMA technology is a small erodible polymer film for application to the buccal mucosa; and the Bioral cochleate drug delivery technology encapsulates a selected drug or therapeutic in a cochleate cylinder. Its pain franchise consists of products utilizing the patented BEMA technology, including ONSOLIS, a fentanyl buccal soluble film for the management of pain in opioid tolerant adult patients with cancer; and BEMA Buprenorphine, which is in the development stage for the treatment of moderate to severe chronic pain, as well as for the treatment of opioid dependence. The company also engages in developing product candidates utilizing the B EMA technology for conditions, such as nausea/vomiting. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Biodelivery Sciences International Inc  (NASDAQ:BDSI)Q4 2018 Earnings Conference CallMarch 14, 2019, 4:30 p.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


  • [By Joseph Griffin]

    BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Director Francis E. Odonnell, Jr. sold 8,000 shares of the firm’s stock in a transaction on Friday, February 1st. The stock was sold at an average price of $4.60, for a total value of $36,800.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Top Penny Stocks For 2023: UFP Technologies Inc.(UFPT)

UFP Technologies, Inc., through its subsidiaries, engages in the design and manufacture of engineered packaging solutions for medical and scientific, automotive, aerospace and defense, computer and electronics, industrial, and consumer markets. The company offers packaging products primarily using polyethylene, polyurethane, cross-linked polyethylene foams, and rigid plastics. Its packaging products include end-cap packs for computers, corner blocks for telecommunications consoles, anti-static foam packs for printed circuit boards, die-cut or routed inserts for cases, molded foam enclosures for orthopedic products, and plastic trays for medical devices and components. UFP Technologies also fabricates and molds component products made from cross-linked polyethylene foam and other materials, as well as engages in laminating fabrics and other materials to cross-linked polyethylene foams, polyurethane foams, and other substrates. The company?s component products include automo tive interior trim, athletic padding, industrial safety belts, medical device components, air filtration, high-temperature insulation, abrasive nail files and other beauty aids, anti-fatigue mats, and shock absorbing inserts used in athletic and leisure footwear. It sells its products primarily under United Foam, Simco Automotive, and Molded Fiber brand names through direct sales force, independent manufacturer representatives, and distributors. The company was founded in 1963 and is headquartered in Georgetown, Massachusetts.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media coverage about UFP Technologies (NASDAQ:UFPT) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UFP Technologies earned a daily sentiment score of 0.03 on Accern’s scale. Accern also assigned headlines about the industrial products company an impact score of 47.0533500754779 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Logan Wallace]

    China XD Plastics (NASDAQ: CXDC) and UFP Technologies (NASDAQ:UFPT) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

Top Penny Stocks For 2023: Flanigan’s Enterprises Inc.(BDL)

Flanigan’s Enterprises, Inc. operates a chain of full-service restaurants and package liquor stores in south Florida. It operates restaurants under Flanigan?s Seafood Bar and Grill name, which offers alcoholic beverages and full food services; and package liquor stores under Big Daddy?s Liquors name that provides brand name and private label liquors, beer, and wines. As of April 2, 2011, the company operated 24 units that consists of restaurants, package liquor stores, and combination restaurants/package liquor stores; 1 adult entertainment club; and franchised 5 units comprising 1 restaurant and 4 combination restaurants/package liquor stores. Flanigan’s Enterprises, Inc. was founded in 1959 and is headquartered in Fort Lauderdale, Florida.

Advisors’ Opinion:

  • [By Logan Wallace]

    Separately, TheStreet lowered shares of Flanigan’s Enterprises from a “b-” rating to a “c+” rating in a report on Thursday, January 31st.

    TRADEMARK VIOLATION WARNING: “Flanigan’s Enterprises, Inc. (BDL) to Issue Annual Dividend of $0.28” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at

    Flanigan’s Enterprises Company Profile

  • [By Peter Graham]

    Small cap Flanigan’s Enterprises (NYSEAMERICAN: BDL) is considered a “beloved” South Florida institution since 1959 welcoming locals and visitors for over 50 years with a portfolio primarily focused on a collection of family-run restaurants, Flanigan’s Seafood Bar And Grill, and retail liquor stores, Big Daddy’s Wine and Liquors. As of September 29, 2018, Flanigan’s Enterprises (i) operated 26 units consisting of restaurants, package liquor stores and combination restaurants/package liquor stores that the Company either owns or has operational control over and partial ownership in; and (ii) franchised an additional five units, consisting of two restaurants, (one of which they operate) and three combination restaurants/package liquor stores (These figures exclude an adult entertainment club which the Company owned but did not operate and was permanently closed on September 20, 2018 when a Federal Court upheld recently enacted legislation prohibiting the operation of the club as then operated). A Form 10-K noted:

  • [By Shane Hupp]

    Bitdeal (CURRENCY:BDL) traded 12.6% lower against the dollar during the 24-hour period ending at 15:00 PM ET on July 10th. Bitdeal has a market cap of $592,736.00 and $1,700.00 worth of Bitdeal was traded on exchanges in the last day. One Bitdeal coin can now be bought for $0.0034 or 0.00000053 BTC on popular exchanges including CoinExchange and Cryptopia. During the last seven days, Bitdeal has traded 11.9% lower against the dollar.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top Penny Stocks For 2023: Luna Innovations Incorporated(LUNA)

Luna Innovations Incorporated engages in the research, development, and commercialization of technologies in the areas of sensing and instrumentation products, and health care products primarily in the United States. The company?s Product and Licensing segment offers test and measurement products to monitor the integrity of fiber optic network and sub-assemblies. This segment provides Optical Vector Analyzer platform, a device for single-measurement, all-parameter analysis of fiber optic components and assemblies up to 150 meters in length; Optical Backscatter Reflectometer, a sensitive diagnostic device, for data and telecommunications companies, and service providers who maintain their own fiber optic networks; and Phoenix laser, a MEMs-based external cavity laser, that offers low noise and precise tuning capability over the C-band. It also offers distributed sensing systems, which comprise multiple sensors whose input is integrated through a fiber optic network and soft ware to detect distributed strain, shape, and temperature; and tunable lasers. In addition, this segment provides health care products, including medical devices for minimally invasive diagnostics, surgery, and therapy; non-invasive monitoring and diagnosis medical devices consisting of emboli detection and classification QUANTIFIER, a non-invasive medical device, that uses quantitative ultrasound technology to count emboli in ex-vivo blood circuit; and nanomaterial-based medical products comprising Trimetasphere nanomaterials. The company?s Technology Development segment provides contract research services to universities, government entities, and corporations. Luna Innovations Incorporated offers its services to energy, telecommunications, life sciences, and defense industries .The company was incorporated in 1990 and is headquartered in Roanoke, Virginia.

Advisors’ Opinion:

  • [By Max Byerly]

    Luna Innovations Incorporated (NASDAQ:LUNA) rose 16.6% during trading on Monday . The company traded as high as $4.14 and last traded at $3.93. Approximately 651,876 shares changed hands during mid-day trading, an increase of 1,262% from the average daily volume of 47,854 shares. The stock had previously closed at $3.37.

  • [By Shane Hupp]

    Luna Coin (CURRENCY:LUNA) traded 5.2% higher against the dollar during the 24 hour period ending at 16:00 PM Eastern on September 26th. Luna Coin has a total market capitalization of $11,480.00 and approximately $13.00 worth of Luna Coin was traded on exchanges in the last day. One Luna Coin coin can now be bought for $0.0067 or 0.00000104 BTC on major exchanges including CoinExchange and YoBit. Over the last seven days, Luna Coin has traded 20.8% lower against the dollar.

  • [By Ethan Ryder]

    Luna Coin (CURRENCY:LUNA) traded up 0.8% against the dollar during the one day period ending at 14:00 PM Eastern on September 18th. One Luna Coin coin can now be bought for about $0.0086 or 0.00000135 BTC on exchanges including CoinExchange and YoBit. Luna Coin has a market cap of $14,603.00 and approximately $2.00 worth of Luna Coin was traded on exchanges in the last day. In the last seven days, Luna Coin has traded down 6.7% against the dollar.

Leave a Reply

Your email address will not be published.